UNIQUE EXPRESSION OF INTEGRIN FIBRONECTIN RECEPTORS IN HUMAN NEUROBLASTOMA CELL-LINES

被引:20
|
作者
YOSHIHARA, T
ESUMI, N
HUMPHRIES, MJ
IMASHUKU, S
机构
[1] UNIV MANCHESTER,DEPT BIOCHEM & MOLEC BIOL,MANCHESTER M13 9PL,LANCS,ENGLAND
[2] KYOTO PREFECTURAL UNIV MED,CHILDRENS RES HOSP,KYOTO 602,JAPAN
关键词
D O I
10.1002/ijc.2910510419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cultured human neuroblastoma cells can be classified morphologically into 3 types: neuroblastic (N), intermediate (I) and substrate adherent (S). Neuroblastoma cells of all types were found to attach and display distinct morphological characteristics on fibronectin, with S-type cells attaching better than N-type cells. Studies of the expression of integrin fibronectin receptors (alpha-3-beta-1, alpha-4-beta-1, alpha-5-beta-1 and alpha-V-beta-1) were carried out using a total of 26 morphologically distinct cell lines and their subpopulations. Fluorescence-activated cell sorting (FACS) analysis and immunoprecipitation revealed that all S-type cells expressed abundant alpha-5-beta-1, while N-type cells barely expressed this molecule. Although alpha-3-beta-1 expression of S-type cells was also higher than that of N-type cells, some N-type cells had significantly increased levels of this molecule. Alpha-4-beta-1 was found to be randomly expressed. All cell lines tested expressed alpha-V-beta-1. Human neuroblastoma cells, the majority of which are N-type cells with very low alpha-5-beta-1 expression, are also contrasted with other childhood cancer cells (rhabdomyosarcoma, Ewing's sarcoma, and glioma), all of which expressed high levels of alpha-5-beta-1. The characteristic expression of integrin fibronectin receptors may account for the clinically unique tumor behavior, and the immunohistochemical staining for integrins may become a useful alternative to conventional histology in differential diagnosis and a marker for prognosis in neuroblastoma.
引用
收藏
页码:620 / 626
页数:7
相关论文
共 50 条
  • [1] EXPRESSION OF HUMAN GLUTAMATE RECEPTORS (GLUR) IN NEUROBLASTOMA CELL-LINES
    KORCZAK, B
    MCWHINNIE, EA
    FLETCHER, EJ
    KAMBOJ, RK
    [J]. NEUROREPORT, 1995, 6 (06) : 905 - 909
  • [2] DELTA-OPIOID RECEPTORS IN HUMAN NEUROBLASTOMA CELL-LINES
    HOCHHAUS, G
    YU, VC
    SADEE, W
    [J]. BRAIN RESEARCH, 1986, 382 (02) : 327 - 331
  • [3] EXPRESSION OF FIBRONECTIN AND ADHESION TO FIBRONECTIN IN MYELOMA CELL-LINES
    HATA, H
    MATSUZAKI, H
    MATSUNO, F
    YOSHIDA, M
    SONOKI, T
    TAKEMOTO, S
    TAKATSUKI, K
    [J]. ACTA HAEMATOLOGICA, 1993, 89 (01) : 26 - 31
  • [4] EXPRESSION AND DISTRIBUTION OF PERIPHERIN PROTEIN IN HUMAN NEUROBLASTOMA CELL-LINES
    PEDERSEN, WA
    BECKER, LE
    YEGER, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (03) : 463 - 470
  • [5] SPECIFIC EXPRESSION OF THE RET PROTOONCOGENE IN HUMAN NEUROBLASTOMA CELL-LINES
    IKEDA, I
    ISHIZAKA, Y
    TAHIRA, T
    SUZUKI, T
    ONDA, M
    SUGIMURA, T
    NAGAO, M
    [J]. ONCOGENE, 1990, 5 (09) : 1291 - 1296
  • [6] DIFFERENTIATION-RELATED EXPRESSION OF ADHESION MOLECULES AND RECEPTORS ON HUMAN NEUROBLASTOMA TISSUES, CELL-LINES AND VARIANTS
    GROSS, N
    FAVRE, S
    BECK, D
    MEYER, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) : 85 - 91
  • [7] PRODUCTION OF FIBRONECTIN AND ADHERENCE TO FIBRONECTIN BY HUMAN MYELOMA CELL-LINES
    VANRIET, I
    DEGREEF, C
    DELFAVERO, H
    DEMANET, C
    VANCAMP, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) : 258 - 265
  • [8] EFFECTS OF HOMOHARINGTONINE ON HUMAN NEUROBLASTOMA CELL-LINES
    TEBBI, CK
    CHERVINSKY, D
    MURPHY, T
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 425 - 425
  • [9] GENE-EXPRESSION OF THE INSULIN-LIKE GROWTH-FACTORS AND THEIR RECEPTORS IN HUMAN NEUROBLASTOMA CELL-LINES
    MARTIN, DM
    YEE, D
    CARLSON, RO
    FELDMAN, EL
    [J]. MOLECULAR BRAIN RESEARCH, 1992, 15 (3-4): : 241 - 246
  • [10] CD44 EXPRESSION AND MODULATION ON HUMAN NEUROBLASTOMA TUMORS AND CELL-LINES
    GROSS, N
    BECK, D
    BERETTA, C
    JACKSON, D
    PERRUISSEAU, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) : 471 - 475